BioNexus Gene Lab Corp.: 10-Q filed 2021-08-12
What BioNexus Gene Lab Corp. reported in its quarterly report filed 2021-08-12 (fiscal Q2 2021): 29 published measures, 82 facts as tagged in accession 0001477932-21-005366.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-08-12
- Fiscal period
- fiscal Q2 2021
- Accession
- 0001477932-21-005366 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioNexus Gene Lab Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 9,448,123 | USD | |
| At 2020-12-31 | 10,115,293 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 2,634,899 | USD | |
| At 2020-12-31 | 3,453,139 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 6,813,224 | USD | |
| At 2021-03-31 | 6,792,430 | USD | |
| At 2020-12-31 | 6,662,154 | USD | |
| At 2020-06-30 | 6,199,934 | USD | |
| At 2020-03-31 | 6,192,217 | USD | |
| At 2019-12-31 | 1,122,364 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,482,705 | USD | |
| At 2020-12-31 | 2,787,692 | USD | |
| At 2020-06-30 | 1,287,111 | USD | |
| At 2019-12-31 | 859,076 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 28,262 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 367,006 | USD | 181 |
| 2021-01-01 to 2021-03-31 | 338,744 | USD | 90 |
| 2020-04-01 to 2020-06-30 | -35,841 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,033,803 | USD | 182 |
| 2020-01-01 to 2020-03-31 | 1,069,644 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -819,892 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -1,134,546 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 1,473 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 305 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 3,092,171 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 6,541,330 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 1,103,516 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 4,173,542 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -17,182 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -9,389 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -325,528 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 1,732,109 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,127,793 | USD | |
| At 2020-12-31 | 760,787 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 108,280 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 108,280 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 487 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,347 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,683,566 | USD | |
| At 2020-12-31 | 1,785,602 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 139,990 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 482,123 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -33,974 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,039,556 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 7,098,570 | USD | |
| At 2020-12-31 | 7,985,494 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 2,575,793 | USD | |
| At 2020-12-31 | 3,373,598 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,703,136 | USD | |
| At 2020-12-31 | 1,176,170 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 467,607 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 1,050,172 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 159,290 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 814,597 | USD | 182 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 2,624,564 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 5,491,158 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 944,226 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 3,358,945 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 171,218,152 | shares | |
| At 2020-12-31 | 171,218,152 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -5,011,891 | USD | |
| At 2020-12-31 | -5,011,891 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -82,252 | USD | |
| At 2020-12-31 | 133,684 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 51,265 | USD | |
| At 2020-12-31 | 62,529 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 20,794 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 151,070 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 7,717 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 782,665 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 378,046 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 680,965 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 216,993 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 545,411 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 46,022 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 20,259 | USD | 182 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 6,837 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 4,406 | USD | 182 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -44,249 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -44,683 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -526,966 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -28,266 | USD | 182 |
Inspect the source
- Entity
- BioNexus Gene Lab Corp. / CIK 0001737523
- Captured
- 2026-09-21T17:25:37.348Z
- SEC response SHA-256
eebcf668b9e42f0c31bf1fe5b3c17450d7f4d836f715c9cebcc6a4fafbcff983
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001737523.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))